Affiliations 

  • 1 Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan (ROC)
  • 2 Yonsei University College of Medicine, Yonsei University, Seodaemun-gu, South Korea
  • 3 Institute of Digestive Diseases, The Chinese University of Hong Kong, Hong Kong SAR, China
  • 4 Chaudhry Hospital, Ghulam Dastagir Khan Rd, Gujranwala, Pakistan
  • 5 Hepatobiliary Division, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia
  • 6 Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 7 College of Medicine, University of the Philippines, Manila, Philippines
  • 8 King Edward Memorial Hospital, Global Hospital, Mumbai, India
  • 9 Department of Gastroenterology & Hepatology, Singapore General Hospital, Singapore, Singapore
  • 10 Department of Medicine, Siriraj Hospital, Mahidol University, Nakhon Salaya, Thailand
  • 11 Hepatology Department in Ho Chi Minh Medic Medical Center, City Ho Chi Minh, Vietnam
  • 12 Gilead Sciences, Hong Kong, China
  • 13 Kantar Health, Singapore, Singapore
J Viral Hepat, 2022 02;29(2):156-170.
PMID: 34817896 DOI: 10.1111/jvh.13636

Abstract

There are limited data to provide better understanding of the knowledge/awareness of general population towards liver health in Asia. We sought to identify the knowledge gaps and attitudes towards liver health and liver diseases as well as evaluate associated individual-level and macro-level factors based on contextual analysis. An online survey assessing knowledge, awareness and attitudes towards liver health and disease was conducted among 7500 respondents across 11 countries/territories in Asia. A liver index was created to measure the respondents' knowledge level and the degree of awareness and attitudes. Multilevel logistic regression was performed to identify individual factors and contextual effects that were associated with liver index. The overall liver index (0-100-point scale) was 62.4 with 6 countries/territories' liver indices greater than this. In the multilevel model, the inclusion of geographical information could explain for 9.6% of the variation. Residing in a country/territory with higher HBV prevalence (80% IOR: 1.20-2.79) or higher HCV death rate (80% IOR: 1.35-3.13) increased the individual probability of obtaining a high overall liver index. Individual factors like age, gender, education, household income, disease history and health screening behaviour were also associated with liver index (all p-values<0.001). The overall liver index was positively associated with the two macro-level factors viz. HBV prevalence and HCV death rate. There is a need to formulate policies especially in regions of lower HBV prevalence and HCV death rate to further improve the knowledge, awareness and attitudes of the general public towards liver diseases.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.